BackChromocell Therapeutics Overview

Chromocell Therapeutics Long Term Debt

Chromocell Therapeutics's long-term debt is $26M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$25.93M

Peer average

Loading

Chromocell Therapeutics Long Term Debt History

Loading

Chromocell Therapeutics vs. peers: Long Term Debt Comparison

Loading

Chromocell Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chromocell Therapeutics (CHRO) FAQ

Chromocell Therapeutics (CHRO) currently reports a long-term debt of $26M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Chromocell Therapeutics's long-term debt history and peer comparisons.

Chromocell Therapeutics's long-term debt changed from $0 to $26M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chromocell Therapeutics reported $26M in long-term debt as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chromocell Therapeutics, and consider following CHRO for alerts when major investors trade the stock.